The aim of this work is to describe the techniques that have been used for preparation and analysis of whole fetal liver extracts destined for in utero transplantation. Nine fetal livers between 12 and 17 weeks of gestation were prepared: cell counts and assessment of the hematopoietic cell viability were performed on cell suspen- 
Allogeneic transplantation with fetal stem cells has been performed in utero for the treatment of severe immunologic, hematologic, and metabolic diseases, and might represent a promising therapeutic option for selected cases. [1] [2] [3] Fetal hematopoietic stem cells can be considered for in utero direct intraperitoneal transplantation with the following advantages: (1) reduced risk of rejection (immunologic immaturity of the fetus); (2) potential to induce a donor specific immune tolerance; (3) no need for recipient conditioning; (4) availability of space in the developing bone marrow; and (5) sterile in utero environment. 4 They seem most promising when the donor cells have a growth advantage over the recipient's cells (immune deficiencies and syndromes of bone marrow failure). In addition, fetal hematopoietic stem cells could also be considered for postnatal transplantation, depending on the number of stem cells in the samples.
In order to investigate the feasibility of this experimental treatment, a therapeutic protocol has been developed in Lausanne. The source of the stem cells, as proposed by this protocol, is a cell suspension obtained after fetal liver extraction, that will be transplanted intraperitoneally without filtration. 5 The cell content of such suspensions, although having been used in previous clinical trials, has not been described. The cells that are likely to be contained in the liver extracts beside the hematopoietic cells (hepatocytes, cells from the biliary tract, endothelial cells, fibrocytes) can be extrapolated from reports on fetal liver pathology slides, 6, 7 but their relative number, and the number of live cells subsisting after liver cell extraction are not known.
Fetal stem cells have already been studied by several groups, but all reports described fetal hematopoietic cells that have been isolated from the other cells contained in the liver by separation techniques. Their surface marker expression, [8] [9] [10] [11] [12] [13] [14] [15] [16] growth and differentiation in clonogeneic culture, 8, 11, 15, [17] [18] [19] and ability to reconstitute hematopoiesis in vivo in graft experiments, [20] [21] [22] [23] [24] [25] [26] have been reported. The aim of this study is to describe the techniques that have been used for the preparation of nine consecutive fetal livers, and the composition of the cell suspensions obtained after liver extraction. The basic analysis necessary for an adequate assessment of the stem cell content (number of hematopoietic CD34
ϩ cells) and of their quality (viability, ability to differentiate in clonogeneic culture) prior to their clinical use will be presented.
Materials and methods

Fetal livers
The procedure was approved by the ethics committee of the Lausanne University Medical School, and is part of an experimental protocol designed for in utero allografting. Termination of pregancy was performed between the 12th and the 17th week of gestation, according to Swiss law, and had no links with the allograft protocol. The fetal liver donation protocol was explained to women who had already asked for termination (and who fulfilled all serological conditions prescribed by the protocol), and informed consent was obtained for liver donation. Induction of abortion was performed under epidural anesthesia with 200 mg intravaginal misoprostol administration. After expulsion, the fetus was collected in a sterile swab, and the physician performed hepatectomy in a time interval not exceeding 30 min. Dissection of the fetal liver was performed by a median laparotomy using surgical asepsis standards in an operating room. After the opening of the peritoneum, the surgical instruments were changed. The liver was dissected and then transferred in a tube containing 20 ml of sterile albumin 5% (Albumin 5% SRK, Zentrallaboratorium, Blutspendedienst SRK, Bern, Switzerland). In the laboratory, under sterile conditions, a cell suspension was obtained by gently agitating the tube containing the fetal liver. Undissolved parenchyme was dissected in a Petri dish with needles for further cell extraction, and the cells were transferred to a tube. The cell suspension was allowed to sediment for 2 min, and was then transferred to another tube. The debris remaining in the bottom of the first tube was discarded. All samples were checked for viral and bacterial contamination (serological assessment of the donor, and direct bacteriological control of the sample prior to cryopreservation) as prescribed by the protocol and Swiss transplant regulations.
Cell viability
An aliquot of the cell suspension was diluted 1/10 in 5% albumin. This suspension was diluted again 1/2 with Trypan blue stain 0.4% (Gibco BRL, Grand Island, NY, USA). Ten l were placed into a Türk's chamber and the dead non-hepatocytic cells were counted. The result was expressed as a percentage of living non-hepatocytic cells.
Cellular analysis
Numeration of the cells was performed on an aliquot of the cell suspension diluted 1/10 with 5% albumin. This suspension was then diluted again 1/5 with Türk's solution (Hospital Pharmacy, CHUV, Lausanne, Switzerland). Ten l of the solution was placed in a Türk's chamber, and allowed to stand for 2 min. Hepatocytes were easily identified by their morphologic appearance. Only the non-hepatocytic cells were counted. Morphologic examination was performed on fetal liver cell smears, as well as on cytospin slides. For the latter procedure, an aliquot of the cell suspension was diluted in phosphate buffered saline (PBS), 0.02% NaN 3 (Fluka Chemika, Buchs, Switzerland) and 0.2% albumin in order to obtain a concentration of 5 ϫ 10 6 of non-hepatocytic cells/ml. Forty ml of the cell dilution were added to 1160 ml of PBS, and 200 l of this preparation were added to cytospin pots (Shandon, Cytospin 3, Pittsburgh, PA, USA), and centrifuged for 5 min at 500 r.p.m. The slides were removed from the cytospin centrifuge and allowed to dry at room temperature. For cytologic examination, small liver tissue aggregates were smeared on glass slides and allowed to dry. The cell smears, as well as the cytospin slides, were stained with May-Grünwald-Giemsa (MGG) (Merk, Darmstadt, Germany), periodic acid Schiff solution (PAS) (Pathology Institute, Lausanne, Switzerland) or with the alkaline phosphatase anti-alkaline phosphatase (APAAP) technique. APAAP staining was performed according to the manufacturer's instructions (APAAP Kit System, Monoclonal, Dako Corporation, Carpinteria, CA, USA). Anti-CD34 (CD34 anti-HPCA-2, Becton Dickinson, San Jose, CA, USA), -von Willebrand factor (vWF), -cytokeratine, -CD18, -CD19, -CD38, -CD45, -CD90, -CD117, -CD144 antibodies (all from Immunotech, Marseille, France) were used, and the smears were stained with Harris' hematoxylin solution (Merk). On the smears, the cells expressing the corresponding antigens were colored in red, allowing a direct visual control of the morphology of the positive cells.
Clonogeneic cultures
The cells were diluted in Iscove's modified Dulbecco's medium (IMDM) (Gibco BRL, Life Technologies, MD, USA) to a concentration of 1 ϫ 10 5 viable non-hepatocytic cells per ml. Fifty l of IMDM and 100 l of the cell dilution were added to 1.1 ml of methylcellulose medium associated with recombinant growth factors (Methocult GF H4434, Stem Cell Technologies, Vancouver, Canada). One ml of this mixture was added to a 30 mm diameter Petri dish and incubated at 37°C in a humid atmosphere containing 5% CO 2 . The numbers of BFU-E, CFU-GM, and CFU-GEMM were counted after 14 days of culture.
Results
Nine fetal livers were collected for the preparation of hematopoietic stem cells aimed for clinical use. Their characteristics are summarized in Table 1 .
The time interval separating the induction of the abortion procedure and the preparation of the liver cell suspensions varied between 11 and 52 h. Hepatocytes represented 40 to 80% of the cell population and were easily recognised on MGG smears and cytospin slides (Figure 1a, c and d) . Their identity was confirmed by PAS staining revealing the glycogen contained in the cytoplasm, and by the expression of cytokeratin (data not shown). Non-hepatocytic cells represented 20 to 60% of the cell population, and the viability of those cells varied between 30 and 80%. Erythroblasts represented 82 to 95% of the non-hepatocytic cell population (Figure 1b) . Cells from the three hematopoietic lineages (erythroid, myeloid and megakaryocytic) were also identified.
Numerous extra-hematopoietic cells, with a dense nucleus and a fusiform cytoplasm, expressed CD34 ( Figure  1e ). These cells were morphologically identified as endothelial cells, and expressed vWF (Figure 1f ) and CD144 (data not shown) markers of the endothelial cells. Because of their presence, flow cytometric analysis showed a great variation in CD34 expression (data not shown) and could not be used for a reliable quantification of the CD34 ϩ hematopoietic cells. They had to be assessed by manual counting under morphological control (cytospin stained by the APAAP technique) (Figure 1d ).
One to 5% of the non-hepatocytic cell population with (Figure 1c and d) . Calculated on the basis of the living hematopoietic cell content, the liver extracts were shown to contain 3.0 to 34.6 ϫ 10 6 CD34 ϩ live hematopoietic cells. The presence of cells derived from the myeloid lineage (expressing the pan-leukocyte antigens CD18 and CD45), of activated lymphocytes (CD38), of B lymphocytes (CD19), of T lymphocytes (CD 90 and CD117), as well as of megakaryocytes (vWF) was confirmed on smears stained with the APAAP technique (data not shown).
Cell cultures of the liver cell extracts confirmed the presence of colony-forming units able to differentiate in CFU-GM, CFU-GEMM and BFU-E (Table 1) .
Discussion
Nine fetal livers have been prepared. A great variability of the time interval separating the induction of the abortion and the stem cell collection was observed; as expected the viability of the cells decreased with time (R ϭ 0.557), but not significantly (P ϭ 0.337), and all cell suspensions contained a large number of living hematopoietic stem cells, as assessed by their adequate growth and differentiation in clonogeneic culture.
Counts and differentiation of the cells contained in the liver extracts had to be performed manually because of the heterogeneity of the cell populations obtained after extraction. Automated cell counters are not able to differentiate hematopoietic nucleated cells from the cell debris and from the hepatocytes present in liver extracts. Hepatocytes represented 40 to 80% of the cell population, and could easily be recognised morphologically. Hematopoietic cells were counted separately, and their viability was assessed.
Flow cytometry analysis of the cell suspension showed a great variation in CD34 expression. After visual control of smears stained with CD34 by the APAAP technique, the cell suspension showed the presence of numerous extrahematopoietic cells expressing CD34 (Figure 1e ). These cells have been identified as endothelial cells, that probably interfered greatly with the assessment of hematopoietic
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ϩ cells by flow cytometry. Thus hematopoietic CD34
ϩ cells had to be counted manually to allow discrimination between hematopoietic and extra-hematopoietic CD34 ϩ cells. Morphologically and immunophenotypically, the greatest portion of the extra-hematopoietic CD34 ϩ cells was identified as being of endothelial origin, but the presence of hepatocyte precursors expressing CD34 is not excluded. 27 Expression of CD34 on endothelial cells has been previously described, [28] [29] [30] and it has recently been shown that endothelial cells and hematopoietic cells are probably derived from a common precursor embryonic cell. 31, 32 It is likely that fetal liver cell extracts contain such precursor cells. The presence of extra-hematopoietic cells expressing CD34 in fetal liver cell extracts has largely been overlooked in most studies on fetal hematopoietic stem cells, and they may have contributed to an overestimation of the hematopoietic stem cell content of fetal livers. 15 The exact number of hematopoietic stem cells necessary for a transplant in utero has not been established yet. For children and adults, the minimal stem cell number required for rapid hematopoietic reconstitution is between 1 and 3 ϫ 10 6 CD34 ϩ cells/kg. A higher cell number leads to a faster hematopoietic reconstitution. In the nine fetal liver extracts, the number of morphologically assessed viable hematopoietic CD34 ϩ cells varied between 3 and 34.6 ϫ 10 6 /liver, which seems to be sufficient to allow an allograft in a fetus. However, recent reports have shown that very primitive hematopoietic stem cells may not express CD34, [33] [34] [35] raising some concerns about using CD34 alone to assess the presence of hematopoietic stem cells, particularly when working with fetal tissues that may contain earlier CD34 negative progenitors than adult bone marrow.
In summary, collection of large amounts of viable hematopoietic stem cells from fetal livers is possible. The highly heterogeneous cellular content of a whole liver cell extract necessitates the use of techniques that allow a visual examination of the cell morphology to ensure correct cell counts as well as assessment of cell viability. 
